Review Article Best Practice Policy Statement on Urodynamic Antibiotic Prophylaxis in the Non-Index Patient1 Anne P. Cameron, M.D.1, Lysanne Campeau, M.D.C.M., Ph.D., F.R.C.S.C.2, Benjamin M. Brucker, M.D.3, J. Quentin Clemens, M.D.1, Gregory T. Bales, M.D.4, Michael E. Albo M.D.5, Michael Kennelly M.D.6* *Corresponding Author 1. University of Michigan Department of Urology 1500 E. Medical Center Dr. Ann Arbor, MI, 48109 USA 2. Jewish General Hospital E959 3755 Côte Ste-Catherine Road Montreal, QC, Canada, H3T 1E2 3. New York Langone Medical Center NYU Urology Associates 150 East 32nd Street, 2nd Floor New York, NY 10016, USA 4. The University of Chicago, Section of Urology 5841 S Maryland Ave, MC 6038 Chicago, IL, USA 60637 5. UCSD Medical Center Division of Urology 4520 Executive Drive San Diego, CA, 92121 USA 6. *Michael J. Kennelly, MD, FACS, FPMRS Women’s Center For Pelvic Health 2001 Vail Ave, Suite 360 Charlotte, NC 28207 USA Office: 704-304-1160 Fax: 704-304-1161
[email protected] Running Title: SUFU Best Practice Policy Panel Statement on Urodynamic Antibiotics Word Count: 5516 Words Author Manuscript This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/nau.23253 This article is protected by copyright. All rights reserved.